Cargando…

Planning and priority setting for vaccine development and immunization()

We review a sequence of strategic planning efforts over time in the United States, all involving processes to prioritize new vaccine candidates. The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine has been involved in three priority setting processes, each usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Phelps, Charles E., Madhavan, Guruprasad, Gellin, Bruce
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131338/
https://www.ncbi.nlm.nih.gov/pubmed/28017444
http://dx.doi.org/10.1016/j.vaccine.2016.09.072
_version_ 1783517215946964992
author Phelps, Charles E.
Madhavan, Guruprasad
Gellin, Bruce
author_facet Phelps, Charles E.
Madhavan, Guruprasad
Gellin, Bruce
author_sort Phelps, Charles E.
collection PubMed
description We review a sequence of strategic planning efforts over time in the United States, all involving processes to prioritize new vaccine candidates. The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine has been involved in three priority setting processes, each using different metrics and methodologies: infant mortality equivalents (1985–1986), cost-effectiveness (2000), and more recently, the implementation of a software system based on a broader multi-criteria systems approach that can include either of the earlier metrics among other various considerations (2015). The systems approach offers users the flexibility to select, combine, rank, weigh and evaluate different attributes representing their perspectives, assumptions, and particular needs. This approach also overcomes concerns relating to the previous single-metric ranking approaches that yielded lists that, once published, were static, and could not readily accommodate new information about emerging pathogens, new scientific advances, or changes in the costs and performance features of interventions. We discuss the rationale and reasoning behind the design of this multi-criteria decision support approach, stakeholder feedback about the tool, and highlight the potential advantages from using this expanded approach to better inform and support vaccine policies.
format Online
Article
Text
id pubmed-7131338
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-71313382020-04-08 Planning and priority setting for vaccine development and immunization() Phelps, Charles E. Madhavan, Guruprasad Gellin, Bruce Vaccine Article We review a sequence of strategic planning efforts over time in the United States, all involving processes to prioritize new vaccine candidates. The Institute of Medicine of the National Academies of Sciences, Engineering, and Medicine has been involved in three priority setting processes, each using different metrics and methodologies: infant mortality equivalents (1985–1986), cost-effectiveness (2000), and more recently, the implementation of a software system based on a broader multi-criteria systems approach that can include either of the earlier metrics among other various considerations (2015). The systems approach offers users the flexibility to select, combine, rank, weigh and evaluate different attributes representing their perspectives, assumptions, and particular needs. This approach also overcomes concerns relating to the previous single-metric ranking approaches that yielded lists that, once published, were static, and could not readily accommodate new information about emerging pathogens, new scientific advances, or changes in the costs and performance features of interventions. We discuss the rationale and reasoning behind the design of this multi-criteria decision support approach, stakeholder feedback about the tool, and highlight the potential advantages from using this expanded approach to better inform and support vaccine policies. Elsevier Ltd. 2017-01-20 2016-12-22 /pmc/articles/PMC7131338/ /pubmed/28017444 http://dx.doi.org/10.1016/j.vaccine.2016.09.072 Text en © 2016 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Phelps, Charles E.
Madhavan, Guruprasad
Gellin, Bruce
Planning and priority setting for vaccine development and immunization()
title Planning and priority setting for vaccine development and immunization()
title_full Planning and priority setting for vaccine development and immunization()
title_fullStr Planning and priority setting for vaccine development and immunization()
title_full_unstemmed Planning and priority setting for vaccine development and immunization()
title_short Planning and priority setting for vaccine development and immunization()
title_sort planning and priority setting for vaccine development and immunization()
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131338/
https://www.ncbi.nlm.nih.gov/pubmed/28017444
http://dx.doi.org/10.1016/j.vaccine.2016.09.072
work_keys_str_mv AT phelpscharlese planningandprioritysettingforvaccinedevelopmentandimmunization
AT madhavanguruprasad planningandprioritysettingforvaccinedevelopmentandimmunization
AT gellinbruce planningandprioritysettingforvaccinedevelopmentandimmunization